Female cancer patients are less satisfied with the quality of their cancer care than male cancer patients and are more likely to report that their symptoms were not taken seriously and that they had to prove their symptoms to providers.
Albany, NY - Una nueva encuesta "Survivor Views" (Opiniones de sobrevivientes) de la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) muestra que, si bien los programas de asistencia para copagos pueden ayudar a los pacientes con cáncer a pagar los medicamentos que necesitan, algunos no pueden aplicarlos al deducible de su cobertura de salud ni a otros requisitos de gastos de bolsillo, lo que puede crear una barrera para la atención.
An article released today in JAMA Network Open details the potential benefits of using technology to increase patient participation in cancer clinical trials. In a survey of nearly 1,200 recent cancer patients and survivors, more than 80% said they would be willing to use remote technologies and tools in a trial.
The cost of cancer care is substantially impacting the lives of cancer patients and survivors, forcing them to make significant lifestyle changes, and causing some to incur long-term medical debt.
The majority of cancer patients in the United States say they struggle to afford the costs of their cancer care.
Una nueva encuesta proporciona información sobre cómo un programa nacional de licencia familiar y médica remunerada podría beneficiar a los pacientes y sobrevivientes de cáncer que se enfrentan con el absentismo laboral y la pérdida de ingresos debido a su enfermedad.
A new survey shows cancer patients and recent survivors have had a positive experience using telehealth in the wake of the pandemic and are willing to use or adapt to using telehealth services in the future.
Cancer patients and survivors continue to deal with the negative effects of the coronavirus pandemic on their ability to access necessary health care.
According to an article published this week in JAMA Oncology, nearly 1 in 5 cancer patients surveyed said the pandemic would make them less likely to enroll in a trial. The top reason given for not enrolling is fear of COVID-19 exposure.
Cancer patients and survivors continue to experience potentially serious coronavirus-related health care delays and high levels of anxiety associated with the ongoing pandemic.